That is necessary, due to the fact that the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we need to understand how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (last week). And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're designed to do. This was a breakthrough almost no one noticed. However it's going to have extensive ramifications for curing disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment chances in this area, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown market predictions). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe significantly prior to going higher - angel investor. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. However that's not the big concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So believe about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. angel investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many excellent personal companies on the verge of hitting the general public markets And I have actually been dealing with a brand-new way for you to invest even before these business go public.
This opportunity has been developing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover out all the information. Go right here to schedule your area totally free.
Emma Walsh here, handling editor of the Journal. Routine Journal readers understand that tech isn't our usual beat (jeff brown 2020 predictions). And when it concerns tech investing, we leave it to the professionals. Luckily, we have several such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we understand (future report review). In reality, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and predict what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and much more. These patterns are experiencing exponential growth and creating unbelievable opportunities for financiers. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown stock market prediction. But despite what many readers may believe, this is a trend that's just getting started. Despite the fact that the COVID-19 pandemic disrupted supply chains last year, an excellent 250 million 5G-enabled devices were still offered.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (angel investor). Losing 2 months of production and sales actually impacts the number of 5G gadgets are sold in the calendar year. When you consider all of that, offering 250 million units is remarkable. More significantly, the delays brought on by the pandemic produced a lots of pent-up demand. Which demand is now going to be pushed into 2021. In fact, I anticipate that more than 500 million 5G devices will be shipped in 2021 - second wave. And that's not my only 5G prediction When I've discussed 5G in the past, I've described its three different phases.
In Phase Two, 5G devices go on sale. 5G phones and other products begin to reach consumers. And in Stage Three, 5G services begin to be provided (jeff brown genome sequencing). That's when we begin to see applications operating on 5G networks. Think about things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase Three by this summertime. This begins something of a virtuous cycle: Many people do not actually care about the innovation. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In fact, 5G is going to open up a suite of extraordinary applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment opportunities going forward will be enormous. Stepping away from 5G, the next crucial innovation I foresee in 2021 is CRISPR genetic modifying. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software application.
The program can crash or not operate properly. CRISPR utilizes a comparable concept however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can correct these "typos." For years, CRISPR was mostly a niche innovation that wasn't well understood. And throughout that time, there were really only three business running in this area. However things are altering. CRISPR is no longer just theoretical. We're seeing real results. We're dealing with illness and seeing that this innovation simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This whole market is successfully a greenfield opportunity.
There's space for many business to exist in this area. exponential growth. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software application can precisely anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is very important because the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been a trial-and-error process. However now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however a number of drug therapies produced using this innovation. This was among those advancements that nearly nobody noticed. However it's going to have extensive implications for treating illness. And, obviously, there will be lots of investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it drew back possibly substantially before going higher. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever published was on bitcoin - exponential growth. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that question any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. genetic sequencer stock jeff brown. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the details is up to date as of February 2021, however we might not independently validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like ability to select winning innovation stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an exceptional point of view on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares a number of his finest picks in the Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively predicted some of the greatest financial events of the past 20 years. Although he does not appear to release his choices to the public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it right whenever, but Jeff Brown's precise forecasts have actually earned him legions of devoted fans. That says a lot about his ability. The Near Future Report is released by Brownstone Research, a popular financial research publisher. Brownstone Research provides several research services with a variety of expertises - jeff brown genetic sequencer stock.
The business is likewise associated with Bonner & Partners, another well-respected research publisher - united arab emirates. On its site, Brownstone states its mission is to supply retail financiers with professional-grade research study: "For too long, the very best investment research has actually not been available to private financiers. It has been generally reserved for financial investment banks, hedge funds, private equity, and high-net-worth clients. the legacy report predictions. The mission of Brownstone Research is to make that sort of exclusive research study readily available to any investors looking to acquire an edge in the marketplaces. The goal is simple to provide distinct and rewarding investment research study found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research, and he also works as the firm's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you understand even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. jeff brown predictions 2021. Everything he touches relies on gold! Jeff is well aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown believes S.A.V. biotech stock. could be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying two advanced technologies: expert system and electric cars. Musk hopes the combination will help him develop the first fully-autonomous, self-driving cars ever. It's absolutely nothing except the vehicle market's Holy Grail. As you know, electric cars and self-driving automobile stocks have actually been huge this year, however the Wall Street device has approved hype without much concrete result. In spite of an extreme boost in competition over the past few years, Brown still thinks Musk has the very best chance of putting everything together.
tech could be the magic string that connects all of it together. S.A.V. means Shared Autonomous Automobile, and it could be the future of transport. Generally, this technology would permit you to lease your cars and truck as a self-governing, self-driving taxi when you're not using it. You just get out of the automobile and press a button on an app that informs the automobile to "sign up with the fleet." Next thing you understand, you're relaxing on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a significant piece of the profits. It sounds crazy, but it might be closed than you believe.